Analyst Research

Report Title Price
Provider: Reuters Investment Profile
Provider: Sadif Analytics Prime
Provider: Wright Reports
Provider: Edison Investment Research

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Biosynex SA Receives the CE mark for Three New Products

Wednesday, 23 Oct 2013 11:45am EDT 

Biosynex SA announced that it has received the CE mark for three new products: IMMUNOQUICK HIV, IMMUNOQUICK HCV and IMMUNOQUICK HBsAg. These products are used to detect HIV and hepatitis B and C. 

Company Quote

0.07 +1.38%
18 Sep 2014